Variant report
Variant | nsv528440 |
---|---|
Chromosome Location | chr1:56412081-56420193 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:10)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:2)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
(count:10 , 50 per page) page:
1
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | CEBPB | chr1:56413288-56413390 | HepG2 | liver: | n/a | chr1:56413334-56413345 |
2 | CEBPB | chr1:56413125-56413530 | Hela-S3 | cervix: | n/a | chr1:56413334-56413345 |
3 | CTCF | chr1:56417200-56417350 | GM12801 | blood: | n/a | n/a |
4 | E2F4 | chr1:56414714-56414993 | MCF10A-Er-Src | breast: | n/a | n/a |
5 | E2F4 | chr1:56413901-56413919 | MCF10A-Er-Src | breast: | n/a | n/a |
6 | EP300 | chr1:56413167-56413451 | Hela-S3 | cervix: | n/a | n/a |
7 | GATA3 | chr1:56414220-56414330 | SH-SY5Y | brain: | n/a | n/a |
8 | POLR2A | chr1:56419116-56419149 | GM12878 | blood: | n/a | n/a |
9 | POLR2A | chr1:56419583-56419829 | H1-neurons | neurons: | n/a | n/a |
10 | POLR2A | chr1:56415331-56415421 | MCF10A-Er-Src | breast: | n/a | n/a |
No data |
No data |
(count:2 , 50 per page) page:
1
No. | lncRNA name | Chromosome Location | lncRNA alias |
---|---|---|---|
1 | lnc-PRKAA2-6 | chr1:56415505-56415792 | NONHSAT003429 |
2 | lnc-PRKAA2-6 | chr1:56415506-56415792 | XLOC_000209 |
No data |
No data |
Variant related genes | Relation type |
---|---|
ENSG00000230250 | TF binding region |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs12081053 | chr1:56412081-56412082 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
2 | rs6656718 | chr1:56412089-56412090 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
3 | rs564487400 | chr1:56412166-56412167 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs533424731 | chr1:56412170-56412171 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs550414841 | chr1:56412178-56412179 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs61777621 | chr1:56412220-56412221 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
7 | rs74434474 | chr1:56412251-56412252 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs181111143 | chr1:56412302-56412303 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs142370420 | chr1:56412306-56412307 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs535063981 | chr1:56412354-56412355 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs551775602 | chr1:56412363-56412364 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs559335332 | chr1:56412366-56412367 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs570792000 | chr1:56412415-56412416 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs571079593 | chr1:56412431-56412432 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs150525969 | chr1:56412518-56412519 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs576163040 | chr1:56412610-56412611 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs185344037 | chr1:56412617-56412618 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs555084151 | chr1:56412624-56412625 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs139512875 | chr1:56412666-56412667 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs540653910 | chr1:56412687-56412688 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs189709349 | chr1:56412712-56412713 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs6660039 | chr1:56412729-56412730 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
23 | rs543761577 | chr1:56412747-56412748 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs181985636 | chr1:56412789-56412790 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs562008500 | chr1:56412791-56412792 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs545135981 | chr1:56412793-56412794 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs529500931 | chr1:56412827-56412828 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs186367702 | chr1:56412845-56412846 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs11448683 | chr1:56412864-56412865 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs397774493 | chr1:56412871-56412872 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs398102732 | chr1:56412872-56412873 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs563037102 | chr1:56412897-56412898 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs191715569 | chr1:56412934-56412935 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs183611266 | chr1:56412953-56412954 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs186520697 | chr1:56412989-56412990 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs571692528 | chr1:56412994-56412995 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs78998732 | chr1:56413026-56413027 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs562785923 | chr1:56413027-56413028 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs75964560 | chr1:56413117-56413118 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs34702909 | chr1:56413125-56413126 | Weak transcription Enhancers | TF binding region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
41 | rs535337939 | chr1:56413154-56413155 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
42 | rs72906393 | chr1:56413185-56413186 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
43 | rs6662998 | chr1:56413260-56413261 | Weak transcription Enhancers | TF binding region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
44 | rs55689401 | chr1:56413269-56413270 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
45 | rs557383630 | chr1:56413305-56413306 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
46 | rs72906399 | chr1:56413337-56413338 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
47 | rs75192525 | chr1:56413372-56413373 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
48 | rs149703104 | chr1:56413380-56413381 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
49 | rs574251574 | chr1:56413385-56413386 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
50 | rs12758651 | chr1:56413408-56413409 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | mRNA abundance |
Disease | PMID | Source |
---|---|---|
Papillary thyroid carcinoma | 21436994 | CNVD |
Adenoid cystic carcinoma | 18698036 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Wilms tumour | 21544195 | CNVD |
Coronary Disease | 20032323 | CNVD |
Prostate cancer | 21965145 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Stargardt''s disease | 17277736 | CNVD |
Neuroblastoma | 17897457 | CNVD |
Uveal melanoma | 21693616 | CNVD |
Cancer | 21637783 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Neuroblastoma | 21484798 | CNVD |
Non-syndromic sensorineural hearing loss | 22290220 | CNVD |
Liposarcoma | 21253554 | CNVD |
Breast cancer | 21264507 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Astrocytoma | 17387387 | CNVD |
Cancer | 21499728 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
Neuroblastoma | 17535989 | CNVD |
Pheochromocytoma | 17535989 | CNVD |
Prostate cancer | 16705090 | CNVD |
Astrocytoma | 17934521 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Neuroblastoma | 18664255 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Gastrointestinal stromal cancer | 19259404 | CNVD |
Gastrointestinal stromal cancer | 20470368 | CNVD |
Gastrointestinal stromal cancer | 17535989 | CNVD |
Neuroblastoma | 17533364 | CNVD |
Paraganglioma | 17535989 | CNVD |
Pulmonary chondroma | 17535989 | CNVD |
Myofibroblastic sarcoma | 19369631 | CNVD |
Breast cancer | 17603634 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
HIV/AIDS | 22032296 | CNVD |
Schizophrenia | 19415332 | CNVD |
Non-syndromic sensorineural hearing loss | 21030649 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Autism | 22495311 | CNVD |
Non-small cell lung cancer | 21385341 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Chordoma | 21602918 | CNVD |
Acute lymphoblastic leukemia | 17443227 | CNVD |
Melanoma | 18172304 | CNVD |
Multiple myeloma | 16461302 | CNVD |
Melanoma | 17363583 | CNVD |
Cancer | 21129771 | CNVD |
Autosomal dominant nocturnal frontal lobe epilepsy | 18472482 | CNVD |
Hirschsprung''s Disease | 21712996 | CNVD |
Non-small cell lung cancer | 20864512 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Thrombocytopenia-absent radius syndrome | 21933853 | CNVD |
Psychiatric disorder | 22848183 | CNVD |
Diffuse large b-cell lymphoma | 18287131 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Burkitt''s lymphoma | 18698080 | CNVD |
Breast cancer | 20409316 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Lung cancer | 18438408 | CNVD |
Splenic marginal zone lymphoma | 21957467 | CNVD |
Breast cancer | 17393978 | CNVD |
Cervical cancer | 21062161 | CNVD |
Cancer | 21183584 | CNVD |
Prostate cancer | 18632612 | CNVD |
Breast cancer | 21785460 | CNVD |
Breast cancer | 21364760 | CNVD |
Rett syndrome | 21593744 | CNVD |
Meckel-Gruber syndrome | 21572526 | CNVD |
Breast cancer | 16620391 | CNVD |
Multiple myeloma | 16616336 | CNVD |
Malignant mesothelioma | 18160781 | CNVD |
Pleural malignant mesothelioma | 18160781 | CNVD |
head and neck squamous cell carcinoma | 17671120 | CNVD |
Prostate cancer | 16573809 | CNVD |
Breast cancer | 16608533 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Breast cancer | 21509527 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Developmental delay | 19490664 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Ovarian cancer | 21720365 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr1:56402000-56416800 | Weak transcription | Aorta | Aorta |
2 | chr1:56404600-56416200 | Weak transcription | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
3 | chr1:56410600-56418600 | Weak transcription | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |
4 | chr1:56413000-56413800 | Enhancers | Dnd41 | blood |
5 | chr1:56413200-56413800 | Enhancers | Hela-S3 | cervix |
6 | chr1:56416200-56418200 | Enhancers | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
7 | chr1:56416400-56417400 | Enhancers | Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells | embryonic stem cell |
8 | chr1:56416400-56417600 | Enhancers | NHDF-Ad | bronchial |
9 | chr1:56416800-56417200 | Enhancers | Muscle Satellite Cultured Cells | -- |
10 | chr1:56416800-56417200 | Enhancers | Aorta | Aorta |
11 | chr1:56416800-56417400 | Enhancers | Bone Marrow Derived Cultured Mesenchymal Stem Cells | Bone marrow |
12 | chr1:56417200-56418600 | Weak transcription | Aorta | Aorta |
13 | chr1:56417200-56420600 | Weak transcription | Muscle Satellite Cultured Cells | -- |
14 | chr1:56417400-56420400 | Weak transcription | Bone Marrow Derived Cultured Mesenchymal Stem Cells | Bone marrow |
15 | chr1:56417400-56420600 | Weak transcription | Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells | embryonic stem cell |
16 | chr1:56417600-56419400 | Weak transcription | NHDF-Ad | bronchial |
17 | chr1:56418200-56419600 | Weak transcription | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
18 | chr1:56418600-56419400 | ZNF genes & repeats | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |
19 | chr1:56419200-56419400 | ZNF genes & repeats | Aorta | Aorta |
20 | chr1:56419400-56421400 | Enhancers | NHDF-Ad | bronchial |
21 | chr1:56419400-56425200 | Weak transcription | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |
22 | chr1:56419600-56421400 | Enhancers | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |